Altimmune Inc (ALT)
7.14
-0.22
(-2.99%)
USD |
NASDAQ |
May 07, 15:29
Altimmune Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.0079 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.0021 |
June 30, 2019 | 0.0074 |
March 31, 2019 | 0.0095 |
December 31, 2018 | 0.0119 |
September 30, 2018 | 0.0507 |
June 30, 2018 | 0.0522 |
March 31, 2018 | 0.0143 |
December 31, 2017 | 0.0133 |
Date | Value |
---|---|
September 30, 2017 | 0.0112 |
June 30, 2017 | 0.0082 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.0306 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.0136 |
March 31, 2015 | 0.0249 |
December 31, 2014 | 0.0408 |
September 30, 2014 | 0.0549 |
June 30, 2014 | 0.1141 |
March 31, 2014 | 0.1784 |
December 31, 2013 | 0.3847 |
September 30, 2013 | 0.1739 |
June 30, 2013 | 0.2561 |
March 31, 2013 | 0.3811 |
December 31, 2012 | 0.3242 |
September 30, 2012 | 0.2912 |
June 30, 2012 | 0.18 |
March 31, 2012 | 0.2388 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.0079
Maximum
Jun 2020
0.0009
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
Eli Lilly and Co | 2.046 |
Amgen Inc | 12.75 |
Pfizer Inc | 0.7959 |
Viking Therapeutics Inc | -- |
Precision BioSciences Inc | 1.188 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 210.64M |
Total Liabilities (Quarterly) | 16.54M |
Shareholders Equity (Quarterly) | 194.10M |
Current Ratio | 17.26 |